European Cancer Forum 2025: Innovation, Security and Sustainability
DUO-O trial: Durvalumab + Bevacizumab + Olaparib Improves PFS in Newly Diagnosed BRCA-Wild-Type Ovarian Cancer
10 Most Promising Cancer Drugs Not Yet Approved in 2025: Solid Tumors Edition by OncoDaily
Tanja Obradovic: Eventful 2025 Year for Cancer Drugs-45 New or Accelerated Approvals by FDA
CancerWorld Issue #110 (December) is Live
A New Invention: Nanoparticle-Based Salivary Biosensor for Early Detection of Oral Squamous Cell Carcinoma
Advancing Childhood Cancer Care at the 2025 St. Jude Global Alliance Convening
Samra Turajlić: Honoured to Receive the 2026 Pezcoller–EACR Translational Cancer Award
